MENU
SONN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sonnet BioTherapeutics Holdings (SONN) Ownership - Who owns Sonnet BioTherapeutics Holdings?
Profile
Industry
N/A
Address
100 Overlook Center
Phone
+1 609 375-2227
Employees
12
Web
https://www.sonnetbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.05M
P/E Ratio
0.29
Total Cash
3.55M
Projected Growth
N/A
Total Debt
150.19K
Revenue
N/A
Risk (Beta)
1.42
Dividend Yield
N/A
Total Cash/Share
5.21
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price
Fundamentals
SONN
Capitalization
2.05M
P/E Ratio
0.29
Risk (Beta)
1.42
Dividend Yield
N/A
Total Cash
3.55M
Total Cash/Share
5.21
Total Debt
150K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
N/A
ROE
N/A
Book Value
2.62M
P/B Ratio
0.78
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
522
Current Ratio
1.65
Current Revenue Per Employee
1552.17
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
68.36
Revenue To Assets
N/A
Shares Held By Institutions
600K
Shares Outstanding - Current
683K
Total Liabilities
3.18M
Total Volume MTD
N/A
Value
1
Gain YTD
-78.448
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development of biologic drugs with enhanced single or bispecific mechanisms
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
100 Overlook Center
Phone
+1 609 375-2227
Employees
12
Web
https://www.sonnetbio.com